Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Neurological Involvements in Covid-19: A Hospital-Based Study Publisher



Montazerlotfelahi H1 ; Norouzi M2 ; Askarimoghaddam F2 ; Hashemnejad MA3 ; Sarabi NB3 ; Qorbani M4 ; Dehghani M5 ; Ashrafi M6 ; Mostafavi K7 ; Ketabforoush AHME3 ; Nikkhah A8
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Pediatric Neurology, Imam Ali Hospital, Faculty of Medicine, Alborz University of medical sciences, Karaj, Iran
  2. 2. Department of the Pediatrics, Imam Ali Hospital, Faculty of Medicine, Alborz University of Medical Sciences, Karaj, Iran
  3. 3. Cellular and Molecular Research Center, Iran University of Medical Sciences, Tehran, Iran
  4. 4. Non-communicable Diseases Research Center, Alborz University of Medical Sciences, Karaj, Iran
  5. 5. Department of Oral and Maxillofacial, Faculty of Dentistry, Tehran Medical Sciences of Islamic Azad University, Tehran, Iran
  6. 6. Department of Pediatric Neurology, Children’s Medical Center, Tehran University of Medical Sciences, Tehran, Iran
  7. 7. Student Research Committee, Faculty of Medicine, Iran University of Medical Sciences, Tehran, Iran
  8. 8. Pediatric Neurology Department, Mofid Children’s Hospital, Faculty of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran

Source: Iranian Journal of Child Neurology Published:2023


Abstract

Objectives The SARS-CoV-2 pandemic is the most challenging crisis in the contemporary world. Besides severe pulmonary involvement, the disease also has several extrapulmonary manifestations, and new signs and symptoms are associated with it every dayThe present study aimed to inquire about the frequency of neurological manifestations and risk factors of COVID-19. Materials & Methods This retrospective, descriptive study included patients with neurological involvement admitted to the Alborz University of Medical Sciences academic hospitals from March 2020 to July 2020 with confirmed COVID-19 infection. The data included in the analysis were the patient’s demographic information, underlying diseases, neurological manifestations, and laboratory findings. Results The study included ninety-five patients with a mean age of fifty-nine. Neurological symptoms and signs were observed in 91.6% and 10.5% of the patients, respectively. The most frequently associated neurological symptoms of COVID-19 were fatigue (49.5%), headache (47.4%), and dizziness (45.3%). Furthermore, the most common neurological involvements included gait disorders (6.3%), cerebellar dysfunction (4.2%), and cerebrovascular accidents (3.15%). Positive troponin was shown to be the strongest predictor of neurological signs (OR=21, P=0.017), followed by WBC≥15,000 (OR = 20.75, P=0.018) and a history of respiratory disease (OR=7.42, P=0.007).Conclusion Neurological symptoms were observed in more than 91% of the patients, while neurological signs were present in 10.5% of the COVID-19 patients. Additionally, positive troponin, WBC≥15,000, and a history of respiratory disease were the strongest predictors of neurological signs. © 2023 The Authors. Published by Shahid Beheshti University of Medical Sciences.
Other Related Docs
12. Late Complications of Covid-19; a Systematic Review of Current Evidence, Archives of Academic Emergency Medicine (2020)
31. Considerations About Cognitive Communication Deficits Following Covid-19, Psychiatry and Clinical Neurosciences (2020)
32. Coronavirus, Its Neurologic Manifestations, and Complications, Iranian Journal of Pediatrics (2020)
35. An Overview on the Seven Pathogenic Human Coronaviruses, Reviews in Medical Virology (2022)